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Summary  Candida  albicans  is  not  a  pathogen  in  healthy  individuals,  but  can  cause  severe
systemic candidiasis  in  immunocompromised  patients.  C.  albicans  has  various  virulence  factors
and activates  the  innate  immune  system.  Speciﬁcally,  C.  albicans  induces  proinﬂammatory
cytokine  production  in  various  cell  types  via  many  receptors,  such  as  Toll-like  receptors  (TLRs)
and C-type  lectin  receptors  (CLRs).  This  microorganism  also  promotes  phagocytosis  via  CLRs  on
macrophages.  In  a  previous  study,  we  found  that  C.  albicans  induces  the  production  of  galectin-C-type  lectin
receptor  (CLR);
Proinﬂammatory
cytokines;
3, which  is  a  known  CLR  that  kills  C.  albicans. This  review  indicates  that  the  use  of  mouthwash
containing  an  antimicrobial  peptide  or  protein  might  be  a  useful  new  oral  care  method  for  the
prevention  of  oral  candidiasis.
© 2014  Japanese  Association  for  Dental  Science.  Published  by  Elsevier  Ltd.  All  rights  reserved.Phagocytosis
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nnate  immunity  is  the  ﬁrst  line  of  non-speciﬁc  defense
gainst  pathogens  such  as  bacteria,  fungi,  and  viruses.
andida  albicans  is  an  oral  indigenous  fungus  and  is  the
ost  frequently  isolated  species  causing  oral  and  systemic
andidiasis  in  hosts  who  are  immunosuppressed  by  malignan-
ies  or  acquired  immunodeﬁciency  syndrome  (AIDS)  [1,2].
his  fungus  ﬁrst  interacts  with  epithelial  cells  that  play crucial  role  in  protecting  the  body  against  invasion  by
athogenic  organisms  and  in  regulating  the  cytokine  net-
ork.  C.  albicans  is  recognized  by  many  receptors  including
oll-like  receptors  (TLRs)  (Fig.  1)  and  C-type  lectin  receptors
igure  1  Toll-like  receptors  for  Candida  albicans. NF-B is
 transcription  factor,  which  is  required  for  proinﬂammatory
ytokine  production.
igure  2  C-type  lectin  receptors  for  Candida  albicans. Syk  is
he spleen  tyrosine  kinase.
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tCLRs)  (Fig.  2),  and  can  induce  proinﬂammatory  cytokine
nd  chemokine  production  in  various  cell  types  including
pithelial  cells,  which  serve  as  barriers  to  oral  candidi-
sis  [3—5].  Live  C.  albicans  can  also  penetrate  tissues
uch  as  oral  mucosa  and  come  into  contact  with  human
ingival  ﬁbroblasts,  the  major  constituents  of  periodontal
issue  [6].  C.  albicans  is  often  aerobically  grown  at  37 ◦C
n  Sabouraud’s  dextrose  broth  supplemented  with  1%  yeast
xtract  in  vitro. While  heat-killed  C.  albicans  lacks  pro-
einase  activity,  the  water-soluble  mannoprotein--glucan
omplex  (CAWS),  which  comprises  cell  wall  components
xtracted  from  C.  albicans,  can  induce  neutrophil  activation
nd  arteritis  in  vivo  [7].
. Phagocytosis of C. albicans and its
irulence factors
hagocytosis  is  one  of  the  ﬁrst  processes  of  innate  immu-
ity.  Macrophages,  neutrophils,  and  dendritic  cells  engulf
.  albicans  [8—10]. The  cell  wall  components  of  C.  albicans
mannans,  -glucans,  and  chitins)  are  virulence  factors
nd  activate  phagocytosis  [11].  Mannans,  which  deﬁne  the
erotypes  of  Candida  spp.,  are  on  the  outermost  surface  of
he  C.  albicans  cell  wall  (Fig.  3).  The  structure  of  C.  albicans
annan  contributes  to  its  recognition  by  macrophages  [12].
eat-killed  C.  albicans  has  increased  surface  expression  of
,3--glucan,  which  is  usually  found  within  mannan  in  the
ell  wall  [10,13]. Phagocytosis  of  -glucans  by  macrophages
an  activate  the  production  of  reactive  oxygen  species
ROS),  which  is  critical  for  pathogen  killing,  although  live  C.
lbicans  suppresses  ROS  production  in  phagocytes  [8,10,14].
hitin  is  a  homopolymer  of  1,4-N-acetylglucosamine  and  a
allmark  component  of  the  cell  walls  of  almost  all  fungi.
annose  receptor  (MR)  and  dectin-1  may  be  chitin  recep-
ors,  but  this  has  not  yet  been  conﬁrmed  [15,16].
Figure  3  Cell  wall  of  Candida  albicans.
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In  addition  to  the  functions  listed  above,  C.  albicans
secretes  proteinases  [11,17].  Sap5p,  one  of  the  secreted
aspartyl  proteinases,  degrades  E-cadherin,  the  predominant
protein  in  epithelial  adherens  junctions  [18].  C.  albicans  also
change  morphology  from  yeast  to  a  hypha,  the  latter  form
of  which  can  escape  the  phagosome  [19].  In  vitro, the  inges-
tion  of  yeast  activates  dendritic  cells  to  produce  interleukin
(IL)-12,  which  is  required  for  the  differentiation  of  T  helper
type  1  cells,  whereas  ingestion  of  hyphae  inhibits  cytokine
production.  Thus,  C.  albicans  hyphae  are  also  capable  of
avoiding  the  adaptive  immune  system.
3. Antimicrobial peptides against C. albicans
3.1.  LL-37
Antimicrobial  peptides  are  synthesized  and  secreted  by  vari-
ous  cells  including  epithelial  cells,  neutrophils,  and  immune
cells.  Human  LL-37  is  an  antimicrobial  peptide  that  is
chemotactic  for  neutrophils  and  monocytes.  The  peptide
inhibits  C.  albicans  adhesion  to  plastic  surfaces  and  kills  the
microorganism  [20,21].  LL-37  also  disrupts  the  cell  mem-
brane  of  C.  albicans  and  causes  an  efﬂux  of  nucleotides  and
proteins  with  molecular  masses  of  up  to  40  kDa  [22].
3.2.  -Defensin
The  -defensin  family,  produced  by  epithelial  cells,  acts
against  gram-positive  and  gram-negative  bacteria,  fungi,
and  enveloped  viruses  in  vitro  [23].  Six  human  -defensins
have  been  identiﬁed  and  are  present  in  gingival  epithelia,
saliva,  and  gingival  crevicular  ﬂuid  [24].  In  particular,  human
-defensins  2 and  3  demonstrate  antifungal  activity  against
C.  albicans  [25,26].
3.3.  Histatin
Histatins  are  basic  histidine-rich  proteins  secreted  in  human
parotid  and  submandibular-sublingual  saliva  in  humans  [27].
Among  histatins,  histatin  5  is  secreted  by  human  salivary
glands  and  has  the  most  potent  fungicidal  activity  against
C.  albicans.  The  antimicrobial  peptide  causes  small  mem-
brane  defects  much  smaller  than  those  induced  by  LL-37
and  nucleotide  leakage  from  C.  albicans  [22,28].
4. Receptors for C. albicans
4.1.  Toll-like  receptors
Toll-like  receptors  (TLRs)  are  capable  of  recognizing  a vari-
ety  of  pathogens  and  induce  defense  responses  such  as
proinﬂammatory  cytokine  production  in  response  to  infec-
tion  [29].  As  shown  in  Fig.  1,  TLR2  recognizes  -glucan  of
C.  albicans  while  TLR4  senses  mannans  of  the  microorgan-
ism  and  induces  cytokine  production  [3,30].  Interestingly,
TLR4-mediated  proinﬂammatory  signals  are  lost  during  ger-
mination  of  Candida  blastoconidia  into  hyphae  [31].  In
contrast,  macrophages  from  TLR2  knockout  mice  exhibit
decreased  production  of  tumor  necrosis  factor  (TNF)-,
which  plays  a  role  in  the  induction  of  diabetes,  in  response
k
p
o
c61
o  both  Candida  blastoconidia  and  hyphae.  Candida  hyphae,
n  the  other  hand,  stimulate  the  production  of  IL-10,  an
nti-inﬂammatory  cytokine,  through  TLR2-dependent  mech-
nisms.  However,  targeted  deletion  of  TLR2  and  TLR4  did  not
ffect  phagocytosis  of  C.  albicans  [32,33]. TLR9  localizes  to
ntracellular  components  such  as  endosomes  and  recognizes
ungal  DNA  [32,34].
.2.  Dectin-1,  dectin-2,  and  dectin-3
ectin-1,  a  C-type  lectin,  is  a member  of  the  -glucan  recep-
or  family  and  important  in  phagocytosis  of  macrophages  by
.  albicans  (Fig.  2).  Dectin-1  synergizes  with  TLR2  and  TLR4
or  TNF- production  by  macrophages  [30,35—38].  The  -
lucan-activated  dectin-1  moves  to  lipid  raft  microdomains,
hich  play  a  role  in  facilitating  the  signaling,  for  activa-
ion  of  phagocytosis  in  dendritic  cells  [39].  Dectin-1  also
ctivates  neutrophils  to  promote  C.  albicans  clearance  [40].
n  addition,  dectin-1  increases  MHC  class  II presentation  of
ungal-derived  antigens  [9].
Dectin-2  is  also  C-type  lectin  receptor  for  fungi  and
ouples  with  the  Fc  receptor    chain,  which  induces  inter-
alization  [41].  Dectin-2  recognizes  the  -mannans  of  C.
lbicans  but  not  -glucan  and  induces  NF-B  activation,
hich  is  required  for  proinﬂammatory  cytokine  production,
uch  as  IL-6  and  IL-8  [42,43].  The  C-type  lectin  receptor
orms  a heterodimeric  pattern-recognition  receptor  with
ectin-3  for  host  defense  against  fungal  infection  [44].
ectin-3  is  known  to  have  high  transcript  amounts  in  per-
toneal  macrophages,  bone  marrow,  and  the  spleen  and  is
apable  of  speciﬁc  recognition  of  C.  albicans  hyphae  [45].
.3.  Galectin-3
alectin-3  is  a  -galactoside-binding  C-type  lectin
xpressed  on  various  cells,  and  binds  to  molecules  contain-
ng  galactose-1,4-N-acetylglucosamine,  such  as  epidermal
rowth  factor  receptor,  integrin  1,  and  mucin  [46—48].
his  molecule  is  associated  with  TLR2  and  required  for
peciﬁc  recognition  of  C.  albicans  but  not  non-pathogenic
accharomyces  cerevisiae  by  macrophages  [13]. Galectin-3
lso  cooperates  with  dectin-1  to  induce  TNF- production
y  C.  albicans  [49].  On  the  other  hand,  Galectin-3  is
eleased  from  cells  and  functions  extracellularly  to  activate
ells  [50].  Galectin-3  secretion  is  signiﬁcantly  and  rapidly
nduced  by  live  C.  albicans  rather  than  heat-killed  C.
lbicans,  although  only  a  mechanotransduction  mechanism
riggers  the  rapid  secretion  of  galectin-3  into  conditioned
edium  [51,52]. Given  that  1,3--glucan  appears  on  the
urface  of  heat-killed  C.  albicans,  mannan  and  proteinase
ctivity  might  be  more  relevant  than  1,3--glucan  for
alectin-3  secretion.  Released  galectin-3  binds  to  and
ills  C.  albicans  [53,54].  In  addition,  exogenous  galectin-3
ccelerates  the  endocytosis  of  integrin  1  and  regulates
eratinocyte  motility  after  being  released  from  the  cyto-
lasm  [49,55]. Galectin-3  also  induces  the  production
f  macrophage-related  chemokines,  pro-inﬂammatory
ytokines,  and  ROS  [56,57].
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.4.  DC-SIGN
C-SIGN  is  speciﬁcally  expressed  on  the  cell  membrane  of
uman  dendritic  cells  and  captures  C.  albicans  [58,59].
annan  is  the  fungal  carbohydrate  structure  speciﬁcally  rec-
gnized  by  DC-SIGN  and  directly  inﬂuences  the  production
f  IL-6,  which  increases  vascular  permeability  [60].  DC-SIGN
ignaling  also  up-regulates  the  production  of  prostaglandins,
ioactive  lipid  messengers,  by  activating  arachidonic  acid
ascade  with  dectin-1  in  dendritic  cells  [61].
.5.  Mannose  receptor  (MR)
R  was  ﬁrst  described  as  a  mannan  receptor  on  the  surface
f  macrophages  [62].  MR  induces  IL-17,  which  binds  fungal
ells  and  tackles  both  sides  of  the  host-pathogen  interaction
n  response  to  C.  albicans  [63,64].  However,  both  dectin-1
nd  complement  receptor  3  were  found  to  accumulate  at
he  site  of  uptake,  while  MR  accumulated  on  C.  albicans
hagosomes  during  later  stages.  In  addition,  MR  deﬁciency
ed  to  a  reduction  in  TNF- and  MCP-1  production  in  response
o  C.  albicans  uptake  [65].
. Perspectives
ecently,  the  study  of  CLRs  has  emerged  as  one  of  the
ost  active  areas  of  research  in  the  ﬁeld  of  fungal  infec-
ion.  Dectin-1  and  dectin-2  appear  to  play  important  roles
n  determining  host  resistance  to  candidiasis  by  triggering  a
alanced  proinﬂammatory  host  response  to  C.  albicans.  We
reviously  demonstrated  that  C.  albicans  induces  galectin-
 secretion  by  human  gingival  epithelial  cells  and  gingival
broblasts.  Antifungal  drugs  including  amphotericin  B  can
ffectively  treat  candidiasis  but  have  side  effects  such  as
nducing  an  inﬂammatory  response  and  severe  nephrotox-
city  [6,66].  Thus,  the  use  of  mouthwash  containing  an
ntimicrobial  peptide  or  protein  might  be  a  useful  new  oral
are  method  for  the  prevention  of  oral  candidiasis.
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